近岸蛋白
(688137)
| 流通市值：27.01亿 | | | 总市值：27.01亿 |
| 流通股本：6991.75万 | | | 总股本：6991.75万 |
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 每股收益(元) | -0.15 | -1.11 | -0.41 | -0.35 | -0.17 | -0.78 | -0.26 | -0.13 |
| 每股净资产(元) | 28.80 | 28.99 | 29.65 | 29.67 | 29.82 | 29.95 | 30.42 | 30.65 |
| 每股资本公积金(元) | 28.18 | 28.15 | 28.11 | 28.07 | 28.02 | 27.98 | 27.93 | 27.89 |
| 每股未分配利润(元) | -0.40 | -0.25 | 0.44 | 0.51 | 0.69 | 0.86 | 1.37 | 1.50 |
| 每股经营性现金流(元) | -0.20 | -0.19 | -0.25 | -0.20 | -0.19 | 0.19 | 0.28 | 0.33 |
| 净资产收益率(%) | -0.52 | -3.76 | -1.38 | -1.16 | -0.56 | -2.53 | -0.84 | -0.41 |
| 营业总收入(元) | 3724.67万 | 1.46亿 | 1.12亿 | 7209.46万 | 3344.46万 | 1.28亿 | 9207.91万 | 5965.52万 |
营业总收入同比增长(%) | 11.37 | 14.80 | 21.48 | 20.85 | 28.20 | -16.73 | -16.83 | -20.13 | | 归属净利润(元) | -1060.44万 | -7778.34万 | -2885.93万 | -2422.36万 | -1180.84万 | -5441.63万 | -1825.85万 | -890.58万 |
| 归属净利润同比增长(%) | 10.20 | -42.94 | -58.06 | -172.00 | -348.91 | -523.68 | -215.00 | -172.05 |
| 扣非净利润(元) | -1060.31万 | -7712.02万 | -3263.93万 | -2668.47万 | -1240.46万 | -7174.86万 | -3270.74万 | -2299.92万 |
|
| 扣非净利润同比增长(%) | 14.52 | -7.49 | 0.21 | -16.02 | -5.97 | -895.04 | -3384.36 | -9627.24 |
| 毛利率(%) | 70.29 | 67.12 | 64.84 | 64.47 | 62.26 | 62.38 | 64.54 | 63.32 |
| 净利率(%) | -28.47 | -53.12 | -25.80 | -33.60 | -35.31 | -42.66 | -19.83 | -14.93 |
| 资产负债率(%) | 5.82 | 5.43 | 5.23 | 5.30 | 5.49 | 5.25 | 4.85 | 6.32 |
| 存货周转率(次) | 0.17 | 0.69 | 0.54 | 0.36 | 0.17 | 0.60 | 0.40 | 0.27 |